Zhu Shaoying, Yang Hui, Liu Jun, Fu Qingsheng, Huang Wei, Chen Qi, Teschendorff Andrew E, He Yungang, Yang Zhen
Center for Medical Research and Innovation of Pudong Hospital, Fudan University Pudong Medical Center, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Institutes of Biomedical Sciences, Fudan University, 200032, Shanghai, China.
Anhui Province Key Laboratory of Non-coding RNA Basic and Clinical Transformation, Tissue Bank, Central Laboratory, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
Nat Commun. 2025 Jul 1;16(1):5508. doi: 10.1038/s41467-025-60521-x.
MicroRNAs (miRNAs) play key roles in development and disease, and have great biomarker potential. However, because miRNA expression is highly cell-type specific, identifying miRNA biomarkers from complex tissues is hampered by the underlying cell-type heterogeneity. Due to that current single-cell RNA-Seq protocols are lagging behind for quantification of miRNA expression, and most miRNA profiling samples do not have matched mRNA expression or DNA methylation data for cell-type deconvolution, it is an urgent need to develop computational methods for cell-type proportion estimation of bulk-tissue miRNA data. Here we present a novel miRNA expression reference library and deconvolution tool for cell-type composition estimation of complex tissues. We show that our tool is accurate and robust for deconvolution in whole blood as well as in different solid tissues. By applying this tool to a range of different biological contexts, we demonstrate its value for screening of age-associated miRNAs, for monitoring the immune landscape in infectious diseases like COVID-19, as well as for identifying cell-type-specific miRNA biomarkers for early diagnosis and prognosis of human cancers. Our work establishes a computational framework for accurate cell-type mixture deconvolution of miRNA data.
微小RNA(miRNA)在发育和疾病中发挥着关键作用,并且具有巨大的生物标志物潜力。然而,由于miRNA表达具有高度的细胞类型特异性,复杂组织中细胞类型的异质性阻碍了从这些组织中鉴定miRNA生物标志物。由于当前的单细胞RNA测序方案在miRNA表达定量方面滞后,并且大多数miRNA谱分析样本没有用于细胞类型反卷积的匹配mRNA表达或DNA甲基化数据,因此迫切需要开发用于估计组织总体miRNA数据中细胞类型比例的计算方法。在此,我们提出了一种新颖的miRNA表达参考文库和反卷积工具,用于估计复杂组织的细胞类型组成。我们表明,我们的工具在全血以及不同实体组织的反卷积中准确且稳健。通过将该工具应用于一系列不同的生物学背景,我们证明了其在筛选与年龄相关的miRNA、监测COVID-19等传染病中的免疫格局以及鉴定用于人类癌症早期诊断和预后的细胞类型特异性miRNA生物标志物方面的价值。我们的工作建立了一个用于准确反卷积miRNA数据细胞类型混合物的计算框架。